SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CYTOSORBENTS CORPORATION
(NQBB:CTSO Last Sale: 9.38 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details


NQBB: (CTSO : $9.38)
$339,661 million Market Cap at Market Close, July 1, 2022
Medical Equipment SubIndustry up .00% / Health Industry up .00% Today
Monmouth Junction,, NJ Research Report Earnings Snapshot - Last 11/12/18
Fact Sheet
Financial Statements
Peer Comparison


address one of the most challenging unmet medical needs in medicine…the ability to prevent or mitigate multiple organ failure, massive excess of cytokines, or “cytokine storm". Blood is pumped out of the body, through the CytoSorb® cartridge that contains the company’s proprietary blood compatible porous polymer beads, and the “purified” blood is recirculated back to the patient.
Historical Charts    Technical Analysis
No Historical Data available for CTSO

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CTSO $9.38 $9.38 0 .0 $8.21 $9.45 720,043 $8.21 $9.45 36,211,234
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $339,661,375

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex